377 related articles for article (PubMed ID: 15204636)
1. Colloidal gold: a novel nanoparticle vector for tumor directed drug delivery.
Paciotti GF; Myer L; Weinreich D; Goia D; Pavel N; McLaughlin RE; Tamarkin L
Drug Deliv; 2004; 11(3):169-83. PubMed ID: 15204636
[TBL] [Abstract][Full Text] [Related]
2. Phase I and pharmacokinetic studies of CYT-6091, a novel PEGylated colloidal gold-rhTNF nanomedicine.
Libutti SK; Paciotti GF; Byrnes AA; Alexander HR; Gannon WE; Walker M; Seidel GD; Yuldasheva N; Tamarkin L
Clin Cancer Res; 2010 Dec; 16(24):6139-49. PubMed ID: 20876255
[TBL] [Abstract][Full Text] [Related]
3. Direct evidence for rapid and selective induction of tumor neovascular permeability by tumor necrosis factor and a novel derivative, colloidal gold bound tumor necrosis factor.
Farma JM; Puhlmann M; Soriano PA; Cox D; Paciotti GF; Tamarkin L; Alexander HR
Int J Cancer; 2007 Jun; 120(11):2474-80. PubMed ID: 17330231
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of tumor thermal therapy using gold nanoparticle-assisted tumor necrosis factor-alpha delivery.
Visaria RK; Griffin RJ; Williams BW; Ebbini ES; Paciotti GF; Song CW; Bischof JC
Mol Cancer Ther; 2006 Apr; 5(4):1014-20. PubMed ID: 16648573
[TBL] [Abstract][Full Text] [Related]
5. Colloidal gold: a novel nanoparticle for targeted cancer therapeutics.
Powell AC; Paciotti GF; Libutti SK
Methods Mol Biol; 2010; 624():375-84. PubMed ID: 20217609
[TBL] [Abstract][Full Text] [Related]
6. Biodistribution of TNF-alpha-coated gold nanoparticles in an in vivo model system.
Goel R; Shah N; Visaria R; Paciotti GF; Bischof JC
Nanomedicine (Lond); 2009 Jun; 4(4):401-10. PubMed ID: 19505243
[TBL] [Abstract][Full Text] [Related]
7. Biodistribution of colloidal gold nanoparticles after intravenous injection: Effects of PEGylation at the same particle size.
Takeuchi I; Onaka H; Makino K
Biomed Mater Eng; 2018; 29(2):205-215. PubMed ID: 29457594
[TBL] [Abstract][Full Text] [Related]
8. β-lactoglobulin-pectin Nanoparticle-based Oral Drug Delivery System for Potential Treatment of Colon Cancer.
Izadi Z; Divsalar A; Saboury AA; Sawyer L
Chem Biol Drug Des; 2016 Aug; 88(2):209-16. PubMed ID: 26896377
[TBL] [Abstract][Full Text] [Related]
9. Gastrointestinal persorption and tissue distribution of differently sized colloidal gold nanoparticles.
Hillyer JF; Albrecht RM
J Pharm Sci; 2001 Dec; 90(12):1927-36. PubMed ID: 11745751
[TBL] [Abstract][Full Text] [Related]
10. Platinum(IV) prodrug conjugated Pd@Au nanoplates for chemotherapy and photothermal therapy.
Shi S; Chen X; Wei J; Huang Y; Weng J; Zheng N
Nanoscale; 2016 Mar; 8(10):5706-13. PubMed ID: 26900670
[TBL] [Abstract][Full Text] [Related]
11. Magnetic polycarbonate microspheres for tumor-targeted delivery of tumor necrosis factor.
Hu B; Du HJ; Yan GP; Zhuo RX; Wu Y; Fan CL
Drug Deliv; 2014 May; 21(3):204-12. PubMed ID: 24117028
[TBL] [Abstract][Full Text] [Related]
12. In vivo tumor delivery of a recombinant single chain Fv::tumor necrosis factor-alpha fusion [correction of factor: a fusion] protein.
Cooke SP; Pedley RB; Boden R; Begent RH; Chester KA
Bioconjug Chem; 2002; 13(1):7-15. PubMed ID: 11792173
[TBL] [Abstract][Full Text] [Related]
13. Enhanced antitumor potency of polyethylene glycolylated tumor necrosis factor-alpha: a novel polymer-conjugation technique with a reversible amino-protective reagent.
Tsunoda S; Ishikawa T; Yamamoto Y; Kamada H; Koizumi K; Matsui J; Tsutsumi Y; Hirano T; Mayumi T
J Pharmacol Exp Ther; 1999 Jul; 290(1):368-72. PubMed ID: 10381801
[TBL] [Abstract][Full Text] [Related]
14. Antitumor activity of tumor necrosis factor-alpha conjugated with polyvinylpyrrolidone on solid tumors in mice.
Kamada H; Tsutsumi Y; Yamamoto Y; Kihira T; Kaneda Y; Mu Y; Kodaira H; Tsunoda SI; Nakagawa S; Mayumi T
Cancer Res; 2000 Nov; 60(22):6416-20. PubMed ID: 11103807
[TBL] [Abstract][Full Text] [Related]
15. Molecular design of hybrid tumor necrosis factor-alpha III: polyethylene glycol-modified tumor necrosis factor-alpha has markedly enhanced antitumor potency due to longer plasma half-life and higher tumor accumulation.
Tsutsumi Y; Kihira T; Tsunoda S; Kamada H; Nakagawa S; Kaneda Y; Kanamori T; Mayumi T
J Pharmacol Exp Ther; 1996 Sep; 278(3):1006-11. PubMed ID: 8819479
[TBL] [Abstract][Full Text] [Related]
16. Magnetic gold nanoparticle-mediated small interference RNA silencing Bag-1 gene for colon cancer therapy.
Huang W; Liu Z; Zhou G; Tian A; Sun N
Oncol Rep; 2016 Feb; 35(2):978-84. PubMed ID: 26717967
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive study of the drug delivery properties of poly(l-lactide)-poly(ethylene glycol) nanoparticles in rats and tumor-bearing mice.
Shalgunov V; Zaytseva-Zotova D; Zintchenko A; Levada T; Shilov Y; Andreyev D; Dzhumashev D; Metelkin E; Urusova A; Demin O; McDonnell K; Troiano G; Zale S; Safarovа E
J Control Release; 2017 Sep; 261():31-42. PubMed ID: 28611009
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, characterization and in vivo evaluation of a magnetic cisplatin delivery nanosystem based on PMAA-graft-PEG copolymers.
Voulgari E; Bakandritsos A; Galtsidis S; Zoumpourlis V; Burke BP; Clemente GS; Cawthorne C; Archibald SJ; Tuček J; Zbořil R; Kantarelou V; Karydas AG; Avgoustakis K
J Control Release; 2016 Dec; 243():342-356. PubMed ID: 27793687
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics, biodistribution and in vivo efficacy of cisplatin loaded poly(L-glutamic acid)-g-methoxy poly(ethylene glycol) complex nanoparticles for tumor therapy.
Yu H; Tang Z; Zhang D; Song W; Zhang Y; Yang Y; Ahmad Z; Chen X
J Control Release; 2015 May; 205():89-97. PubMed ID: 25529533
[TBL] [Abstract][Full Text] [Related]
20. Molecular design of hybrid tumour necrosis factor alpha with polyethylene glycol increases its anti-tumour potency.
Tsutsumi Y; Kihira T; Tsunoda S; Kanamori T; Nakagawa S; Mayumi T
Br J Cancer; 1995 May; 71(5):963-8. PubMed ID: 7734321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
